EMBC News - Candlesense

embecta to Participate in Investor Events

PARSIPPANY, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based me...

Investor events

about 19 hours ago

Embecta Corp. Reports Third Quarter Fiscal 2025 Financial Results

PARSIPPANY, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and n...

What macro‑economic or industry trends (e.g., reimbursement policy changes, prevalence of diabetes) could amplify or mitigate the stock's reaction to this earnings release? How might the earnings results influence short‑term technical indicators such as momentum, volume, and price‑to‑earnings multiples? Did the earnings call reveal any concerns about supply‑chain constraints or competitive pressures that could affect future performance?

Earnings

19 days ago

embecta Announces Quarterly Cash Dividend

PARSIPPANY, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstand...

How might this dividend announcement affect institutional and retail investor sentiment toward EMBC? What does the dividend suggest about management's confidence in the company's cash generation and future outlook? Are there any tax implications for investors receiving this dividend?

Dividends

19 days ago